Form 8-K - Current report:
SEC Accession No. 0001437749-26-018896
Filing Date
2026-05-29
Accepted
2026-05-29 16:56:34
Documents
29
Period of Report
2026-05-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20260529_8k.htm   iXBRL 8-K 26079
2 EXHIBIT 99.1 ex_969880.htm EX-99.1 10521
7 a01.jpg GRAPHIC 255905
8 a02.jpg GRAPHIC 213645
9 a03.jpg GRAPHIC 209774
10 a04.jpg GRAPHIC 288431
11 a05.jpg GRAPHIC 221329
12 a06.jpg GRAPHIC 207620
13 a07.jpg GRAPHIC 191055
14 a08.jpg GRAPHIC 198288
15 a09.jpg GRAPHIC 164666
16 a10.jpg GRAPHIC 185941
17 a11.jpg GRAPHIC 150295
18 a12.jpg GRAPHIC 147824
19 a13.jpg GRAPHIC 157521
20 a14.jpg GRAPHIC 227480
21 a15.jpg GRAPHIC 203646
22 a16.jpg GRAPHIC 148379
  Complete submission text file 0001437749-26-018896.txt   4537412

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20260529.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20260529_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20260529_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20260529_pre.xml EX-101.PRE 12022
32 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20260529_8k_htm.xml XML 2947
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 261045657
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)